BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36450833)

  • 1. In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model.
    Chen YA; Kankel MW; Hana S; Lau SK; Zavodszky MI; McKissick O; Mastrangelo N; Dion J; Wang B; Ferretti D; Koske D; Lehman S; Koszka K; McLaughlin H; Liu M; Marshall E; Fabian AJ; Cullen P; Marsh G; Hamann S; Craft M; Sebalusky J; Arnold HM; Driscoll R; Sheehy A; Luo Y; Manca S; Carlile T; Sun C; Sigrist K; McCampbell A; Henderson CE; Lo SC
    Gene Ther; 2023 May; 30(5):443-454. PubMed ID: 36450833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo genome editing improves motor function and extends survival in a mouse model of ALS.
    Gaj T; Ojala DS; Ekman FK; Byrne LC; Limsirichai P; Schaffer DV
    Sci Adv; 2017 Dec; 3(12):eaar3952. PubMed ID: 29279867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of a Mouse Model of ALS by In Vivo Base Editing.
    Lim CKW; Gapinske M; Brooks AK; Woods WS; Powell JE; Zeballos C MA; Winter J; Perez-Pinera P; Gaj T
    Mol Ther; 2020 Apr; 28(4):1177-1189. PubMed ID: 31991108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Duan W; Guo M; Yi L; Liu Y; Li Z; Ma Y; Zhang G; Liu Y; Bu H; Song X; Li C
    Gene Ther; 2020 Apr; 27(3-4):157-169. PubMed ID: 31819203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal delivery of AAV-NDNF ameliorates disease progression of ALS mice.
    Cheng W; Huang J; Fu XQ; Tian WY; Zeng PM; Li Y; Luo ZG
    Mol Ther; 2023 Nov; 31(11):3277-3289. PubMed ID: 37766430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
    Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
    Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte-targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast-fatigable motor units in a mouse model of amyotrophic lateral sclerosis.
    Rochat C; Bernard-Marissal N; Källstig E; Pradervand S; Perrin FE; Aebischer P; Raoul C; Schneider BL
    Glia; 2022 May; 70(5):842-857. PubMed ID: 34978340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
    J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
    Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
    Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
    Stoica L; Todeasa SH; Cabrera GT; Salameh JS; ElMallah MK; Mueller C; Brown RH; Sena-Esteves M
    Ann Neurol; 2016 Apr; 79(4):687-700. PubMed ID: 26891182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis.
    Patel P; Julien JP; Kriz J
    Neurotherapeutics; 2015 Jan; 12(1):217-33. PubMed ID: 25404049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal motoneurones are intrinsically more responsive in the adult G93A SOD1 mouse model of amyotrophic lateral sclerosis.
    Jensen DB; Kadlecova M; Allodi I; Meehan CF
    J Physiol; 2020 Oct; 598(19):4385-4403. PubMed ID: 32716521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
    Turner BJ; Ackerley S; Davies KE; Talbot K
    Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subpial delivery of adeno-associated virus 9-synapsin-caveolin-1 (
    Wang S; Ichinomiya T; Savchenko P; Wang D; Sawada A; Li X; Duong T; Li W; Bonds JA; Kim EJ; Miyanohara A; Roth DM; Patel HH; Patel PM; Tadokoro T; Marsala M; Head BP
    Theranostics; 2022; 12(12):5389-5403. PubMed ID: 35910808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation.
    Liu X; Zhang J; Li J; Song C; Shi Y
    Mol Metab; 2022 Sep; 63():101536. PubMed ID: 35772643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.
    Turner BJ; Alfazema N; Sheean RK; Sleigh JN; Davies KE; Horne MK; Talbot K
    Neurobiol Aging; 2014 Apr; 35(4):906-15. PubMed ID: 24210254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.